Cryogenic OGS H1 FY27 standalone revenue Rs 3,035.68 lakh; PAT up 22.5% YoY
For H1 FY27, Cryogenic OGS Ltd reported standalone revenue from operations of Rs 3,035.68 lakh and PAT of Rs 675.92 lakh, up from Rs 2,106.50 lakh and Rs 551.67 lakh in H1 FY26.
Key takeaways
- Rs 3,035.68 lakh standalone revenue from operations in H1 FY27 vs Rs 2,106.50 lakh in H1 FY26
- Rs 675.92 lakh standalone PAT in H1 FY27 vs Rs 551.67 lakh in H1 FY26
- Standalone EBITDA reported at Rs 984.21 lakh in H1 FY27 vs Rs 631.08 lakh in H1 FY26
- Standalone EBITDA margin at 32.42% in H1 FY27 vs 29.96% in H1 FY26
- Standalone EPS for H1 FY27 was Rs 4.73 vs Rs 4.52 in H1 FY26
H1 FY27 · standalone
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 3,035.68 lakh | Rs 2,106.50 lakh | +44.1% |
| PAT | Rs 675.92 lakh | Rs 551.67 lakh | +22.5% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 22.27% of revenue, down 392 bps from 26.19%.
- Revenue rose 44.1% while total expenses rose 38.8%.
• Revenue from operations (standalone, H1 FY27): Rs 3,035.68 lakh, vs Rs 2,106.50 lakh in H1 FY26, as per the profit & loss statement in the investor presentation.
• Total income (standalone, H1 FY27): Rs 3,122.11 lakh, vs Rs 2,171.25 lakh in H1 FY26.
• Total expenditure (standalone, H1 FY27): Rs 2,137.90 lakh, vs Rs 1,540.17 lakh in H1 FY26.
• EBITDA (standalone, H1 FY27): Rs 984.21 lakh, vs Rs 631.08 lakh in H1 FY26.
• Depreciation (standalone, H1 FY27): Rs 44.90 lakh, vs Rs 25.03 lakh in H1 FY26.
• Interest (standalone, H1 FY27): Rs 27.49 lakh, vs Rs 2.04 lakh in H1 FY26.
• Profit before tax – PBT (standalone, H1 FY27): Rs 911.82 lakh, vs Rs 727.96 lakh in H1 FY26.
• Tax (standalone, H1 FY27): Rs 235.90 lakh, vs Rs 176.29 lakh in H1 FY26.
• Profit after tax – PAT (standalone, H1 FY27): Rs 675.92 lakh, vs Rs 551.67 lakh in H1 FY26.
• EBITDA margin (standalone, H1 FY27): 32.42%, vs 29.96% in H1 FY26.
• PAT margin (standalone, H1 FY27): 22.27%, vs 26.19% in H1 FY26.
• EPS (standalone, H1 FY27): Rs 4.73, vs Rs 4.52 in H1 FY26.
According to the profit & loss statement in the investor presentation (labelled "PROFIT & LOSS STATEMENT" and marked "Standalone | ₹ in Lakhs"), Cryogenic OGS Ltd’s standalone revenue from operations for the half year ended 30 September 2026 (H1 FY27) was Rs 3,035.68 lakh, compared with Rs 2,106.50 lakh in the corresponding half year H1 FY26. Total income for H1 FY27 stood at Rs 3,122.11 lakh versus Rs 2,171.25 lakh a year earlier, while total expenditure rose to Rs 2,137.90 lakh from Rs 1,540.17 lakh.
Standalone EBITDA for H1 FY27 was reported at Rs 984.21 lakh, up from Rs 631.08 lakh in H1 FY26. Depreciation increased to Rs 44.90 lakh from Rs 25.03 lakh, and interest expenses rose to Rs 27.49 lakh from Rs 2.04 lakh. Profit before tax for the half year was Rs 911.82 lakh, compared with Rs 727.96 lakh in the same period of the previous year. After a tax charge of Rs 235.90 lakh (Rs 176.29 lakh in H1 FY26), standalone PAT for H1 FY27 came in at Rs 675.92 lakh, up from Rs 551.67 lakh in H1 FY26.
The company also disclosed in the same statement that the standalone EBITDA margin for H1 FY27 was 32.42% against 29.96% in H1 FY26, while the PAT margin was 22.27% versus 26.19% a year earlier. Reported standalone EPS for H1 FY27 was Rs 4.73, compared with Rs 4.52 in H1 FY26. All these figures are stated as unaudited standalone numbers in the investor presentation.
Track Cryogenic Ogs Ltd
Cruxal reads every Cryogenic Ogs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
